创新医疗（002173）9月4日主力资金净买入1.36亿元

Core Viewpoint - Innovation Medical (002173) has shown a significant increase in stock price and trading volume, indicating potential investor interest despite mixed financial performance [1][2]. Financial Performance - As of the latest report, Innovation Medical's total revenue for the first half of 2025 was 402 million yuan, a year-on-year decrease of 1.6% [3]. - The company reported a net profit attributable to shareholders of -11.36 million yuan, which is a year-on-year increase of 29.12% [3]. - The second quarter of 2025 saw a single-quarter revenue of 208 million yuan, reflecting a year-on-year increase of 0.73% [3]. - The gross profit margin stands at 12.06%, significantly lower than the industry average of 35.92% [3]. Market Activity - On September 4, 2025, the stock closed at 24.99 yuan, up 5.31%, with a trading volume of 1.1823 million hands and a total transaction amount of 2.934 billion yuan [1]. - The net inflow of main funds was 136 million yuan, accounting for 4.65% of the total transaction amount [1][2]. - Over the past five days, the stock has experienced fluctuations in fund flows, with notable net outflows from retail investors [2]. Industry Comparison - Innovation Medical's total market capitalization is 11.028 billion yuan, which is below the industry average of 20.374 billion yuan [3]. - The company ranks 34th in net profit and 40th in gross margin within the medical services industry [3]. - The price-to-earnings ratio is -485.32, indicating a loss, while the industry average is 83.81 [3].